The SOL Group produces technical and medical gases and is active in homecare, biotechnology and renewable energies.
SOL S.p.A.
Monza (IT)New on Amplifa
About the SOL Group
The SOL Group, headquartered in Monza (Italy), was founded in 1927 and is an Italian supplier of technical and medical gases. The company operates oxygen, acetylene and air separation plants, including newly built plants in Thessaloniki and Frankfurt (2025), as well as a gas cylinder testing centre in Italy. In addition to its classic gas business, the group is active in homecare ventilation therapy through VIVISOL, in biotechnology with the companies CRYOLAB (cryopreservation), DIATHEVA (monoclonal antibodies, recombinant proteins, molecular kits) and PERSONAL GENOMICS (Next Generation Sequencing), and in the renewable energies sector with hydroelectric power plants with an installed capacity of around 31 MW in Albania, Bosnia and Herzegovina, North Macedonia and Slovenia. The group employs around 7,623 people and generated consolidated revenue of €1,776.1 million in 2025. SOL S.p.A. has been listed on the Milan stock exchange since 1998 and is present in numerous European countries as well as in India, South America, China and Kuwait.
- Site
- Monza
- Processes
- Technical gases, Homecare (VIVISOL), Biotechnology (CRYOLAB, DIATHEVA, PERSONAL GENOMICS), Cryopreservation, Bioshipping, Genomic diagnostics, Renewable energies (hydroelectric power), Testing and maintenance of gas cylinders
- Materials
- Oxygen, Acetylene, Carbon dioxide, Cryogenic liquefied gases
- Certificates
- Integrated Management System (Quality, HSE)
- Founded
- 1927
- Employees
- 7623
- Industries
- Technical gases, Medical gases, Homecare/Healthcare, Biotechnology, Food, Environment
- 01
Production of technical gases (oxygen, acetylene, CO2, air separation)
- 02
Processing and testing of gas cylinders
- 03
Distribution and logistics
- 04
Application services (including homecare, biotechnology)
Products and Gases
Oxygen
Used in industry, medicine and homecare ventilation therapy.
Acetylene
Fuel gas whose production laid the foundation of the company in 1927.
Carbon dioxide
Through its German subsidiary SKS, one of the leading suppliers in the German CO2 market.
Cryogenic liquefied gases
Basis for storage and transport of biological samples (CRYOLAB, Bioshipping).
Locations
Monza
ITHeadquarters
Inside the production
Industries
Additional services
Quality and Management Systems
The SOL Group applies an integrated quality, occupational safety and environmental management system that serves as a common standard for all group companies and is continuously monitored.
| Evidence | Monza |
|---|---|
| Integrated Management System (Quality, HSE) |
History
- 1927
Founded by Giovanni Annoni and Aldo Fumagalli; first oxygen and acetylene plants in Livorno and Ancona.
- 1960
Second generation launches innovation programme; first technical gas plants at major customers such as steel and glass works.
- 1970
Leading supplier in the Italian market; shift from a regional to a national strategy.
- 1987
Start of European expansion with plants, branches and joint ventures.
- 1989
Founding of Vivisol for homecare ventilation therapy.
- 1998
IPO of SOL S.p.A. in Milan.
- 2002
Entry into hydroelectric power (approx. 31 MW) in South Eastern Europe.
- 2010
Market entry into India (joint venture) and entry into biotechnology.
- 2014
Acquisition of SKS, leader in the German CO2 market.
- 2018
Acquisitions in Poland; establishment of a gas cylinder testing centre in Italy.
- 2019
Expansion in homecare to Brazil, Germany (Wanninger) and Switzerland (Spitex Perspecta).
- 2020
Development and production of COVID-19 rapid tests and molecular kits in Italy.
- 2021
Market entry into Shanghai.
- 2022
Majority stake in ITOP; partnership with BHURUKA GASES (India).
- 2023
Partnerships in Ecuador and Peru.
- 2024
Acquisition of PRONEP (Brazil).
- 2025
New air separation plants in Thessaloniki and Frankfurt; majority stake in AENDUO; 20% in Biometan Green; founding of VIVISOL KUWAIT.